Evidence map›Paper›PMID 33330637›Full record

ReviewFrontiers in cardiovascular medicine2020

Current Devices in Mitral Valve Replacement and Their Potential Complications.

Livia Gheorghe, Jorn Brouwer, Dee Dee Wang, Nina Wunderlich, Bushra Rana, Benno Rensing, Frank Eefting, Leo Timmers, Martin Swaans

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in cardiovascular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Livia GheorgheSt. Antonius Hospital, Nieuwegein, Netherlands.
Jorn BrouwerSt. Antonius Hospital, Nieuwegein, Netherlands.
Dee Dee WangHenry Ford Hospital, Detroit, MI, United States.
Nina WunderlichCardiovascular Center Darmstadt, Darmstadt, Germany.
Bushra RanaRoyal Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom.
Benno RensingSt. Antonius Hospital, Nieuwegein, Netherlands.
Frank EeftingSt. Antonius Hospital, Nieuwegein, Netherlands.
Leo TimmersSt. Antonius Hospital, Nieuwegein, Netherlands.
Martin SwaansSt. Antonius Hospital, Nieuwegein, Netherlands.
St. Antonius Ziekenhuis · NLHenry Ford Hospital · USPapworth Hospital NHS Foundation Trust · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral regurgitation is one of the most prevalent valvulopathies worldwide, and its surgical treatment is not feasible in all cases. The elderly and frail with several comorbidities and left ventricular dysfunction are often managed conservatively. Percutaneous treatment (repair or replacement) of the mitral valve has emerged as a potential option for those patients who are at a high risk for surgery. Mitral valve repair with the Mitraclip device proved both increased safety and mortality reduction in patients with severe mitral regurgitation. On the other hand, in the last decade, percutaneous mitral replacement opened new frontiers in the field of cardiac structural interventions. There are few mitral devices; some are in the early phase of development and some are waiting for CE mark of approval. The evolution of these devices was more complicated compared to the aortic technology due to the native mitral valve's complexity and access. This review aims to provide an overview of the current devices, their specific features, and their potential complications.

Indexed as

complicationLVOT obstructionminimal invasive approachmitral replacementmitral valve

Identifiers

PMID33330637
PMCPMC7728606
OpenAlexW3109947515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.